Access the full text.
Sign up today, get DeepDyve free for 14 days.
L. Leick, B. Lindegaard, Dorthe Stensvold, P. Plomgaard, B. Saltin, H. Pilegaard (2007)
Adipose Tissue Interleukin‐18 mRNA and Plasma Interleukin‐18: Effect of Obesity and ExerciseObesity, 15
Y. Aso, K. Okumura, K. Takebayashi, S. Wakabayashi, T. Inukai (2003)
Relationships of plasma interleukin-18 concentrations to hyperhomocysteinemia and carotid intimal-media wall thickness in patients with type 2 diabetes.Diabetes care, 26 9
M. Strączkowski, I. Kowalska, A. Nikołajuk, E. Otziomek, A. Adamska, M. Karolczuk-Zarachowicz, M. Górska (2007)
Increased serum interleukin-18 concentration is associated with hypoadiponectinemia in obesity, independently of insulin resistanceInternational Journal of Obesity, 31
W. Willett, G. Howe, L. Kushi (1997)
Adjustment for total energy intake in epidemiologic studies.The American journal of clinical nutrition, 65 4 Suppl
R. Krogh-Madsen, P. Plomgaard, K. Møller, B. Mittendorfer, B. Pedersen (2006)
Influence of TNF-α and IL-6 infusions on insulin sensitivity and expression of IL-18 in humansAmerican Journal of Physiology-endocrinology and Metabolism, 291
J. Hung, B. McQuillan, C. Chapman, P. Thompson, J. Beilby (2005)
Elevated Interleukin-18 Levels Are Associated With the Metabolic Syndrome Independent of Obesity and Insulin ResistanceArteriosclerosis, Thrombosis, and Vascular Biology, 25
M. Hivert, L. Sullivan, C. Fox, D. Nathan, R. D'Agostino, P. Wilson, J. Meigs (2008)
Associations of adiponectin, resistin, and tumor necrosis factor-alpha with insulin resistance.The Journal of clinical endocrinology and metabolism, 93 8
J. Fain, D. Tichansky, A. Madan (2006)
Most of the interleukin 1 receptor antagonist, cathepsin S, macrophage migration inhibitory factor, nerve growth factor, and interleukin 18 release by explants of human adipose tissue is by the non-fat cells, not by the adipocytes.Metabolism: clinical and experimental, 55 8
G. Colditz, S. Hankinson (2005)
The Nurses' Health Study: lifestyle and health among womenNature Reviews Cancer, 5
J. Hulthe, W. McPheat, A. Samnegård, P. Tornvall, A. Hamsten, P. Eriksson (2006)
Plasma interleukin (IL)-18 concentrations is elevated in patients with previous myocardial infarction and related to severity of coronary atherosclerosis independently of C-reactive protein and IL-6.Atherosclerosis, 188 2
I. Wood, Bohan Wang, J. Jenkins, P. Trayhurn (2005)
The pro-inflammatory cytokine IL-18 is expressed in human adipose tissue and strongly upregulated by TNFα in human adipocytesBiochemical and Biophysical Research Communications, 337
Gary Guilder, Greta Hoetzer, Jared Greiner, B. Stauffer, C. Desouza (2006)
Influence of Metabolic Syndrome on Biomarkers of Oxidative Stress and Inflammation in Obese AdultsObesity, 14
F. Hu, J. Manson, M. Stampfer, G. Colditz, Simin Liu, C. Solomon, W. Willett (2001)
Diet, lifestyle, and the risk of type 2 diabetes mellitus in women.The New England journal of medicine, 345 11
K. Esposito, F. Nappo, F. Giugliano, C. Palo, M. Ciotola, M. Barbieri, G. Paolisso, D. Giugliano (2003)
Meal modulation of circulating interleukin 18 and adiponectin concentrations in healthy subjects and in patients with type 2 diabetes mellitus.The American journal of clinical nutrition, 78 6
F. Hu, Ronald Sigal, J. Rich-Edwards, G. Colditz, C. Solomon, W. Willett, F. Speizer, J. Manson (1999)
Walking compared with vigorous physical activity and risk of type 2 diabetes in women: a prospective study.JAMA, 282 15
J. Yudkin (2003)
Adipose tissue, insulin action and vascular disease: inflammatory signalsInternational Journal of Obesity, 27
B. Thorand, H. Kolb, J. Baumert, W. Koenig, L. Chambless, C. Meisinger, T. Illig, Stephan Martin, C. Herder (2005)
Elevated levels of interleukin-18 predict the development of type 2 diabetes: results from the MONICA/KORA Augsburg Study, 1984-2002.Diabetes, 54 10
Steve Selvin (1991)
Statistical Analysis of Epidemiologic Data
C. Dinarello (2006)
Interleukin 1 and interleukin 18 as mediators of inflammation and the aging process.The American journal of clinical nutrition, 83 2
F. Hu, J. Meigs, Tricia Li, N. Rifai, J. Manson (2004)
Inflammatory markers and risk of developing type 2 diabetes in women.Diabetes, 53 3
A. Field, E. Coakley, A. Must, Jennifer Spadano, N. Laird, W. Dietz, E. Rimm, G. Colditz (2001)
Impact of overweight on the risk of developing common chronic diseases during a 10-year period.Archives of internal medicine, 161 13
R. Kaplan, G. Ho, X. Xue, S. Rajpathak, M. Cushman, T. Rohan, H. Strickler, P. Scherer, K. Anastos (2007)
Within-Individual Stability of Obesity-Related Biomarkers among WomenCancer Epidemiology Biomarkers & Prevention, 16
M. Schulze, C. Solomon, N. Rifai, R. Cohen, J. Sparrow, F. Hu, F. Hu, J. Manson, J. Manson (2005)
Hyperproinsulinaemia and risk of Type 2 diabetes mellitus in womenDiabetic Medicine, 22
T. Skurk, H. Kolb, S. Müller-Scholze, K. Röhrig, H. Hauner, C. Herder (2005)
The proatherogenic cytokine interleukin-18 is secreted by human adipocytes.European journal of endocrinology, 152 6
N. Vilarrasa, J. Vendrell, J. Maravall, M. Broch, A. Estepa, A. Megía, Joan Soler, I. Simón, C. Richart, J. Gómez (2006)
IL-18: Relationship with Anthropometry, Body Composition Parameters, Leptin and Arterial HypertensionHormone and Metabolic Research, 38
K. Esposito, F. Nappo, F. Giugliano, C. Palo, M. Ciotola, M. Barbieri, G. Paolisso, D. Giugliano (2003)
Cytokine milieu tends toward inflammation in type 2 diabetes.Diabetes care, 26 5
Sang-Ah Lee, A. Kallianpur, Y. Xiang, W. Wen, Q. Cai, Da-ke Liu, S. Fazio, M. Linton, W. Zheng, X. Shu (2007)
Intra-individual Variation of Plasma Adipokine Levels and Utility of Single Measurement of These Biomarkers in Population-Based StudiesCancer Epidemiology Biomarkers & Prevention, 16
C. Heidemann, Qi Sun, R. Dam, J. Meigs, Cuilin Zhang, S. Tworoger, C. Mantzoros, F. Hu (2008)
Total and High-Molecular-Weight Adiponectin and Resistin in Relation to the Risk for Type 2 Diabetes in WomenAnnals of Internal Medicine, 149
C. Fischer, L. Perstrup, A. Berntsen, P. Eskildsen, B. Pedersen (2005)
Elevated plasma interleukin-18 is a marker of insulin-resistance in type 2 diabetic and non-diabetic humans.Clinical immunology, 117 2
J. Bruun, B. Stallknecht, J. Helge, B. Richelsen (2007)
Interleukin-18 in plasma and adipose tissue: effects of obesity, insulin resistance, and weight loss.European journal of endocrinology, 157 4
M. Bosch, A. López‑Bermejo, J. Vendrell, M. Musri, W. Ricart, J. Fernandez-Real (2005)
Circulating IL-18 concentration is associated with insulin sensitivity and glucose tolerance through increased fat-free massDiabetologia, 48
Elevated IL-18 levels are associated with higher risk of diabetes. This association is independent of usual risk factors, including BMI and adipokine levels.
Diabetologia – Springer Journals
Published: Oct 1, 2009
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.